September is traditionally observed by health experts and advocates as National Prostate Cancer Awareness Month. In recognition of the month, Philadelphia CyberKnife recently hosted a community event for the 250 plus prostate cancer patients they have treated since 2006.
Prostate cancer is the second most common cancer in American men, with about one in seven men getting prostate cancer during his lifetime. According to the American Cancer Society, there will be over 10,000 new cases of prostate cancer diagnosed in Pennsylvania during the year 2015.
Philadelphia CyberKnife pioneered prostate cancer treatment by being a national early adopter of stereotactic body radiation therapy (SBRT) treatment for prostate cancer. At Philadelphia CyberKnife, SBRT is performed using the CyberKnife® Robotic Radiosurgery System. CyberKnife is a painless, noninvasive treatment system that precisely focuses high dose radiation directly to the prostate cancer, minimizing exposure to surrounding tissues.
Over the years, Philadelphia CyberKnife has completed multiple research and clinical studies demonstrating the benefits associated with SBRT treatment. The entire physician team and staff at Philadelphia CyberKnife is committed to conducting research that will lead to a better understanding of stereotactic radiation treatment and its impact on patients’ lives.
During the event, John Lamond, M.D., and Rachelle Lanciano, M.D., radiation oncologists at Philadelphia CyberKnife, spoke about how important Philadelphia CyberKnife’s patients have been to the long term data necessary to make SBRT an acceptable treatment option in treating prostate cancer. The physicians thanked the patients for choosing Philadelphia CyberKnife and let them know they have helped change the course of medicine.
The prostate cancer survivor celebration was an enormous success and Philadelphia CyberKnife would like to thank everyone that attended and helped with the event!
For more information about how Philadelphia CyberKnife treats prostate cancer, please click here.
Photo caption: Philadelphia CyberKnife physicians and staff praise prostate cancer survivors at inaugural celebration event.